期刊
NEUROPHARMACOLOGY
卷 64, 期 -, 页码 566-578出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuropharm.2012.06.020
关键词
Noninvasive brain stimulation; Repetitive transcranial magnetic stimulation (TMS, rTMS); Transcranial direct current stimulation (tDCS); Theta burst stimulation (TBS); Neuropsychiatry; Psychology; Cognition; Cognitive; Depression; Schizophrenia; Alzheimer's disease; ADHD; Autism
资金
- Michael J Fox Foundation
- RJ Goldberg Foundation
- Berenson Foundation
- National Institutes of Health
- Harvard Clinical and Translational Science Center (Harvard Catalyst) [NCRR-NIH UL1 RR025758]
Cognitive impairment is a core symptom of many neuropsychiatric diseases and a key contributor to the patient's quality of life. However, an effective therapeutic strategy has yet to be developed. Noninvasive brain stimulation techniques, namely transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS), are promising techniques that are under investigation for a variety of otherwise treatment-resistant neuropsychiatric diseases. Notably, these tools can induce alterations in neural networks subserving cognitive operations and thus may provide a means for cognitive restoration. The purpose of this article is to review the available evidence concerning cognitive enhancing properties of noninvasive brain stimulation in neuropsychiatry. We specifically focus on major depression. Alzheimer's disease, schizophrenia, autism and attention deficit hyperactivity disorder (ADHD), where cognitive dysfunction is a major symptom and some studies have been completed with promising results. We provide a critical assessment of the available research and suggestions to guide future efforts. This article is part of a Special Issue entitled 'Cognitive Enhancers'. (C) 2012 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据